| Impairment of angiogenesis by fatty acid synthase inhibition involves mTOR malonylation U Bruning, F Morales-Rodriguez, J Kalucka, J Goveia, F Taverna, ... Cell metabolism 28 (6), 866-880. e15, 2018 | 197 | 2018 |
| Discovering targets of non-enzymatic acylation by thioester reactivity profiling RA Kulkarni, AJ Worth, TT Zengeya, JH Shrimp, JM Garlick, AM Roberts, ... Cell chemical biology 24 (2), 231-242, 2017 | 97 | 2017 |
| A chemoproteomic portrait of the oncometabolite fumarate RA Kulkarni, DW Bak, D Wei, SE Bergholtz, CA Briney, JH Shrimp, ... Nature chemical biology 15 (4), 391-400, 2019 | 92 | 2019 |
| Identifying potent, selective protein tyrosine phosphatase inhibitors from a library of Au (I) complexes MR Karver, D Krishnamurthy, RA Kulkarni, N Bottini, AM Barrios Journal of medicinal chemistry 52 (21), 6912-6918, 2009 | 80 | 2009 |
| A chemically stable fluorescent marker of the ureter J Cha, RR Nani, MP Luciano, G Kline, A Broch, K Kim, JM Namgoong, ... Bioorganic & medicinal chemistry letters 28 (16), 2741-2745, 2018 | 49 | 2018 |
| Global profiling of acetyltransferase feedback regulation DC Montgomery, JM Garlick, RA Kulkarni, S Kennedy, A Allali-Hassani, ... Journal of the American Chemical Society 138 (20), 6388-6391, 2016 | 46 | 2016 |
| PEST‐domain‐enriched tyrosine phosphatase and glucocorticoids as regulators of anaphylaxis in mice DD Obiri, N Flink, JV Maier, A Neeb, D Maddalo, W Thiele, A Menon, ... Allergy 67 (2), 175-182, 2012 | 27 | 2012 |
| Co-opting a bioorthogonal reaction for oncometabolite detection TT Zengeya, JM Garlick, RA Kulkarni, M Miley, AM Roberts, Y Yang, ... Journal of the American Chemical Society 138 (49), 15813-15816, 2016 | 25 | 2016 |
| Modular synthesis of cell-permeating 2-ketoglutarate esters TT Zengeya, RA Kulkarni, JL Meier Organic letters 17 (10), 2326-2329, 2015 | 19 | 2015 |
| Statin therapy inhibits fatty acid synthase via dynamic protein modifications AG Trub, GR Wagner, KA Anderson, SB Crown, GF Zhang, JW Thompson, ... Nature Communications 13 (1), 2542, 2022 | 16 | 2022 |
| Epigenetic regulation by endogenous metabolite pharmacology RA Kulkarni, DC Montgomery, JL Meier Current opinion in chemical biology 51, 30-39, 2019 | 16 | 2019 |
| Photoinducible oncometabolite detection RA Kulkarni, CA Briney, DR Crooks, SE Bergholtz, C Mushti, SJ Lockett, ... ChemBioChem 20 (3), 360-365, 2019 | 13 | 2019 |
| Thiuram Disulfides as Pseudo‐irreversible Inhibitors of Lymphoid Tyrosine Phosphatase RA Kulkarni, SM Stanford, NA Vellore, D Krishnamurthy, MR Bliss, ... ChemMedChem 8 (9), 1561-1568, 2013 | 12 | 2013 |
| Bioorthogonal pro-metabolites for profiling short chain fatty acylation WR Sinclair, JH Shrimp, TT Zengeya, RA Kulkarni, JM Garlick, H Luecke, ... Chemical Science 9 (5), 1236-1241, 2018 | 11 | 2018 |
| pCAP-based peptide substrates: the new tool in the box of tyrosine phosphatase assays SM Stanford, D Krishnamurthy, RA Kulkarni, CE Karver, E Bruenger, ... Methods 65 (2), 165-174, 2014 | 11 | 2014 |
| 3-amino-pyridine derivatives for the treatment of metabolic disorders N Deka, KJ Padiya, SR Bajare, RA Kulkarni, TU Khan, S Hariharan, ... US Patent 8,269,010, 2012 | 10 | 2012 |
| Substrate selection influences molecular recognition in a screen for lymphoid tyrosine phosphatase inhibitors RA Kulkarni, NA Vellore, MR Bliss, SM Stanford, MD Falk, N Bottini, ... ChemBioChem 14 (13), 1640-1647, 2013 | 7 | 2013 |
| 3-amino-pyridine derivatives for the treatment of metabolic disorders N Deka, KJ Padiya, SR Bajare, RA Kulkarni, TU Khan, S Hariharan, ... US Patent App. 13/584,043, 2013 | 3 | 2013 |
| Chemical Cryptology of Cancer’s Histone Code RA Kulkarni, JL Meier Chemistry & biology 21 (11), 1419-1421, 2014 | 2 | 2014 |
| Synthesis and Evaluation of a Stable Isostere of Malonyllysine SE Bergholtz, Y Jing, RA Kulkarni, TT Zengeya, JL Meier bioRxiv, 2020.08. 23.263285, 2020 | | 2020 |
